Literature DB >> 9358551

Interaction of human IgE with soluble forms of IgE high affinity receptors.

J Liu1, J Ruppel, S J Shire.   

Abstract

PURPOSE: Interaction of human IgE with its high affinity receptor (Fc epsilon RI) on mast cells and basophils is an important step for initiating IgE mediated immune responses. To characterize the IgE and Fc epsilon RI interaction, we investigated this interaction in terms of stoichiometry and binding affinity in solution. The binding of IgE and IgE Fc epsilon RI alpha chain, the extracellular portion of IgE high affinity receptor (sFc epsilon RI alpha) was compared with the binding of IgE and IgE immunoadhesin (Fc epsilon RI alpha-IgG).
METHODS: The interaction was characterized by analytical ultracentrifugation, size exclusion chromatography, light scattering and ELISA.
RESULTS: We show that the sFc epsilon RI alpha is only able to bind to one IgE, while the immunoadhesin can bind to two IgE. The interaction between IgE and Fc epsilon RI is very strong. Both forms of soluble receptors have similar intrinsic binding affinity with IgE.
CONCLUSIONS: Both soluble receptors (Fc epsilon RI alpha-IgG and sFc epsilon RI alpha) can block the binding of IgE to its high affinity receptors on cell surface. The Fc epsilon RI alpha-IgG is a better IgE binding protein than sFc epsilon RI alpha at physiological relevant conditions. A humanized anti-IgE monoclonal antibody, rhuMAb E25 that also can block the binding of IgE to its high affinity receptors appears to bind to IgE at slightly different regions or in a different manner as the soluble forms of IgE receptors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9358551     DOI: 10.1023/a:1012116604499

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  16 in total

1.  The alpha subunit of the human IgE receptor (FcERI) is sufficient for high affinity IgE binding.

Authors:  J Hakimi; C Seals; J A Kondas; L Pettine; W Danho; J Kochan
Journal:  J Biol Chem       Date:  1990-12-25       Impact factor: 5.157

2.  Designing CD4 immunoadhesins for AIDS therapy.

Authors:  D J Capon; S M Chamow; J Mordenti; S A Marsters; T Gregory; H Mitsuya; R A Byrn; C Lucas; F M Wurm; J E Groopman
Journal:  Nature       Date:  1989-02-09       Impact factor: 49.962

Review 3.  The receptor with high affinity for immunoglobulin E.

Authors:  H Metzger; G Alcaraz; R Hohman; J P Kinet; V Pribluda; R Quarto
Journal:  Annu Rev Immunol       Date:  1986       Impact factor: 28.527

4.  Morphologic and immunologic characterization of human basophils developed in cultures of cord blood mononuclear cells.

Authors:  T Ishizaka; A M Dvorak; D H Conrad; J R Niebyl; J P Marquette; K Ishizaka
Journal:  J Immunol       Date:  1985-01       Impact factor: 5.422

5.  Characterization of complex formation by humanized anti-IgE monoclonal antibody and monoclonal human IgE.

Authors:  J Liu; P Lester; S Builder; S J Shire
Journal:  Biochemistry       Date:  1995-08-22       Impact factor: 3.162

6.  Human IgE receptor alpha-chain IgG chimera blocks passive cutaneous anaphylaxis reaction in vivo.

Authors:  M Haak-Frendscho; J Ridgway; R Shields; K Robbins; C Gorman; P Jardieu
Journal:  J Immunol       Date:  1993-07-01       Impact factor: 5.422

7.  Purification and characterization of IgE produced by human myeloma cell line, U266.

Authors:  S Ikeyama; S Nakagawa; M Arakawa; H Sugino; A Kakinuma
Journal:  Mol Immunol       Date:  1986-02       Impact factor: 4.407

8.  Biological properties of a CD4 immunoadhesin.

Authors:  R A Byrn; J Mordenti; C Lucas; D Smith; S A Marsters; J S Johnson; P Cossum; S M Chamow; F M Wurm; T Gregory; J E Groopman; D J Capon
Journal:  Nature       Date:  1990-04-12       Impact factor: 49.962

9.  Expression of high-affinity binding of human immunoglobulin E by transfected cells.

Authors:  L Miller; U Blank; H Metzger; J P Kinet
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

Review 10.  Biology and chemistry of low affinity IgE receptor (Fc epsilon RII/CD23).

Authors:  M L Richards; D H Katz
Journal:  Crit Rev Immunol       Date:  1991       Impact factor: 2.214

View more
  2 in total

1.  The effect of formulation excipients on protein stability and aerosol performance of spray-dried powders of a recombinant humanized anti-IgE monoclonal antibody.

Authors:  J D Andya; Y F Maa; H R Costantino; P A Nguyen; N Dasovich; T D Sweeney; C C Hsu; S J Shire
Journal:  Pharm Res       Date:  1999-03       Impact factor: 4.200

Review 2.  Assessment and significance of protein-protein interactions during development of protein biopharmaceuticals.

Authors:  Sandeep Yadav; Jun Liu; Thomas M Scherer; Yatin Gokarn; Barthélemy Demeule; Sonoko Kanai; James D Andya; Steven J Shire
Journal:  Biophys Rev       Date:  2013-03-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.